$SLS·4

Galena Biopharma, Inc. · Sep 18, 4:36 PM ET

Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Sep 18, 2014

Insider Transaction Report

Form 4
Period: 2014-09-16
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-09-16+200,000200,000 total
    Exercise: $2.23Exp: 2024-09-16Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
  • [F2]The option will vest in 12 equal quarterly installments over three years beginning on August 21, 2014 (the retroactive effective date of the Reporting Person's employment agreement), provided, in each case, that the Reporting Person remains in continuous employ of the Issuer through such quarterly vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT